trial · primary record
MCLA-158
Advanced/Metastatic Solid Tumors
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 560 |
| Primary completion | 2028-11 |
| Primary endpoint | Escalation: Number of patients with Dose Limiting Toxicities (DLTs) during Cycle 1 |
| Registry ID | NCT03526835 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:24.688Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03526835
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.